Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
45.35
-4.15 (-8.38%)
Nov 17, 2026, 1:30 PM CST

Pell Bio-Med Technology Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-408.27-423.94-389.42-398.76-230.13-188.96
Depreciation & Amortization
74.447.0746.2845.430.3829.28
Other Amortization
0.050.050.60.220.660.88
Loss (Gain) From Sale of Assets
-0.01-0.140.13-0.2
Loss (Gain) From Sale of Investments
7.56-5.130.62---
Loss (Gain) on Equity Investments
-00-0.11-0.110-0.01
Stock-Based Compensation
72.6175.1258.97143.0646.6824.96
Provision & Write-off of Bad Debts
0---0.07-
Other Operating Activities
-51.67-29.44-6.8-2.98-1.15-
Change in Accounts Receivable
-0.05-1.313.85-1.56-1.62-3.39
Change in Inventory
-62.32-0.44-2.420.82-0.347.15
Change in Accounts Payable
14.051.24-2.531.422.42-5.07
Change in Unearned Revenue
-----0.75-
Change in Other Net Operating Assets
-81.4555.4930.6932.37-7.227.13
Operating Cash Flow
-435.1-281.29-260.12-179.99-160.98-107.84
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-173.27-226.41-263.79-16.49-6.5-14.48
Sale of Property, Plant & Equipment
0.13-13.49-0.05
Sale (Purchase) of Intangibles
-23.68-1.19-0.19--2-
Investment in Securities
58.38-290.31228.72-402.15-536100
Other Investing Activities
-14.0620.78-61.25-4.49-6.46-1.67
Investing Cash Flow
-152.5-497.14-95.51-419.63-550.9683.9

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--200-5-
Total Debt Issued
--200-5-
Short-Term Debt Repaid
--100--5--
Long-Term Debt Repaid
--27.55-25.65-25.07-10.76-10.26
Lease Payments
-29.33-27.55-25.65-25.07-10.76-10.26
Total Debt Repaid
-29.33-127.55-25.65-30.07-10.76-10.26
Net Debt Issued (Repaid)
-29.33-127.55174.35-30.07-5.76-10.26
Issuance of Common Stock
1,874572.67331.17625.77759.345.02
Repurchase of Common Stock
----0.8--
Other Financing Activities
-212.64109.8-14.99-
Financing Cash Flow
1,845657.76615.32594.89768.56-5.23

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
1,259-120.67259.69-4.7356.62-29.17

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-608.37-507.7-523.91-196.48-167.48-122.32
Free Cash Flow Growth
------
Free Cash Flow Margin
-1881.52%-1615.65%-2668.77%-1089.53%-976.14%-875.12%
Free Cash Flow Per Share
-0.49-0.43-0.46-0.21-0.21-0.18
Levered Free Cash Flow
-270.66-763.73-588.73-53.62-86.4-
Unlevered Free Cash Flow
-270.37-762.45-587.32-52.02-85.55-
Free Cash Flow After Leases
-637.7-535.25-549.56-221.55-178.24-132.57

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
2.052.052.262.561.361.52
Cash Income Tax Paid
0.420.421.20.50-
Change in Working Capital
-129.7754.9829.633.05-7.4925.81